Two items require written clarification from WellMedr before any enrollment decision: the 90-day guarantee terms versus the published refund policy, and the platform's contingency plan for continued medication access as the regulatory environment evolves
(2026, March 4)
Before subscribing, verify four things: the compounding pharmacy's state licensure and PCAB accreditation, the specific formulation (pure peptide vs peptide plus B12 or niacinamide), the refund and cancellation policy, and the current FDA regulatory posture on compounded GLP-1s, which has shifted multiple times in 2024 through 2026
I said, okay, I don't care how the body makes it
Third, and more speculatively, weight loss was perhaps considered an unserious reason to take a drug, more a question of willpower than pharmacology